New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales decreased 1.3% sequentially in September after
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit
MBX-1416 is under clinical development by MBX Biosciences Inc and currently in Phase II for Hypoglycemia.
By Company Name No Filter Selected Bristol-Myers Squibb (669) Merck (456) Novartis (367) AstraZeneca (309) F. Hoffmann-La Roche (283) AbbVie (266) Pfizer (254) BeiGene (192)
HUC-3443 is under clinical development by Huons and currently in Phase II for Idiopathic (Essential) Hypertension.
RPA-601 is under clinical development by Rocket Pharmaceuticals and currently in Phase I for Cardiomyopathy.
By Company Name No Filter Selected Bristol-Myers Squibb (669) Merck (456) Novartis (367) AstraZeneca (309) F. Hoffmann-La Roche (283) AbbVie (266) Pfizer (254) BeiGene (192)
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,